Chinese english Germany Japanese Korea

rel-(4R,7R,8S)-4,8-Dihydro-8-[(Z)-(hydrox yimino)(hydroxymethylamino)methyl]-1- methyl-6-oxo-1H-4,7-methanopyrazolo[3,4-e] [1,3]diazepin-5(6H)-yl hydrogen sulfate

rel-(4R,7R,8S)-4,8-Dihydro-8-[(Z)-(hydrox yimino)(hydroxymethylamino)methyl]-1- methyl-6-oxo-1H-4,7-methanopyrazolo[3,4-e] [1,3]diazepin-5(6H)-yl hydrogen sulfate Struktur
2251812-49-2
CAS-Nr.
2251812-49-2
Englisch Name:
rel-(4R,7R,8S)-4,8-Dihydro-8-[(Z)-(hydrox yimino)(hydroxymethylamino)methyl]-1- methyl-6-oxo-1H-4,7-methanopyrazolo[3,4-e] [1,3]diazepin-5(6H)-yl hydrogen sulfate
Synonyma:
rel-(4R,7R,8S)-4,8-Dihydro-8-[(Z)-(hydrox yimino)(hydroxymethylamino)methyl]-1- methyl-6-oxo-1H-4,7-methanopyrazolo[3,4-e] [1,3]diazepin-5(6H)-yl hydrogen sulfate
CBNumber:
CB111557673
Summenformel:
C10H14N6O7S
Molgewicht:
362.32
MOL-Datei:
2251812-49-2.mol
Request For Quotation

rel-(4R,7R,8S)-4,8-Dihydro-8-[(Z)-(hydrox yimino)(hydroxymethylamino)methyl]-1- methyl-6-oxo-1H-4,7-methanopyrazolo[3,4-e] [1,3]diazepin-5(6H)-yl hydrogen sulfate Eigenschaften

Sicherheit

rel-(4R,7R,8S)-4,8-Dihydro-8-[(Z)-(hydrox yimino)(hydroxymethylamino)methyl]-1- methyl-6-oxo-1H-4,7-methanopyrazolo[3,4-e] [1,3]diazepin-5(6H)-yl hydrogen sulfate Chemische Eigenschaften,Einsatz,Produktion Methoden

rel-(4R,7R,8S)-4,8-Dihydro-8-[(Z)-(hydrox yimino)(hydroxymethylamino)methyl]-1- methyl-6-oxo-1H-4,7-methanopyrazolo[3,4-e] [1,3]diazepin-5(6H)-yl hydrogen sulfate Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

rel-(4R,7R,8S)-4,8-Dihydro-8-[(Z)-(hydrox yimino)(hydroxymethylamino)methyl]-1- methyl-6-oxo-1H-4,7-methanopyrazolo[3,4-e] [1,3]diazepin-5(6H)-yl hydrogen sulfate Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 0)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
  • rel-(4R,7R,8S)-4,8-Dihydro-8-[(Z)-(hydrox yimino)(hydroxymethylamino)methyl]-1- methyl-6-oxo-1H-4,7-methanopyrazolo[3,4-e] [1,3]diazepin-5(6H)-yl hydrogen sulfate
  • 2251812-49-2
Copyright 2019 © ChemicalBook. All rights reserved